Irvine, CA
Marriott Irvine Spectrum
August 13-14, 2026
7.0 CE/CME/CPE and ABPath MOC

Advancing Precision Cancer Care Through Multidisciplinary Collaboration

Irvine, CA
August 13-14, 2026

EVENT PARTNER

Advancing the Diagnostic-to-Treatment Continuum in Hematologic Malignancies –
Irvine, CA

Advancing Hematologic Care Through Collaboration and Clinical Insight

Irvine, California, is home to a rapidly growing hub of clinical innovation and translational research. This program is presented in partnership with City of Hope, Orange County, bringing together hematologists, oncologists, pathologists, and healthcare professionals to explore evolving treatment strategies and real-world approaches to patient care.

The program will be co-chaired by Tanya Siddiqi, MD, Medical Director of Lymphoma and IEC Programs at City of Hope Orange County and Professor in the Department of Hematology and Hematopoietic Cell Transplantation. Dr. Siddiqi is a nationally recognized leader in lymphoid malignancies and cellular therapies, with extensive experience in clinical trials and the development of novel treatment approaches in CLL and lymphoma.

Joining her as co-chair is Lisa Lee, MD, Associate Clinical Professor in the Department of Hematology and Hematopoietic Cell Transplantation at City of Hope. Dr. Lee brings a strong clinical focus on hematologic malignancies and multidisciplinary care, with expertise in translating emerging therapies into practical treatment strategies.

This clinically focused program highlights contemporary management strategies across hematologic malignancies, with an emphasis on practical, real-world decision-making and evolving treatment paradigms. Through expert-led sessions and interactive panel discussions, the meeting will explore advances in myeloid and lymphoid malignancies, cellular therapies including CAR-T and bispecific antibodies, and emerging approaches in multiple myeloma, amyloidosis, and monoclonal gammopathies.

Participants will gain actionable insights into treatment sequencing, toxicity management, and patient selection, while engaging in multidisciplinary dialogue that supports informed clinical decision-making. Continuing education credits (CME/CE and MOC) are planned for this activity.

Agenda

August 13, 2026
11:30 AMRegistration & Check-in
12:15 PMWelcome and Introductions Tanya Siddiqi, MD, City of Hope; Lisa Lee, MD, City of Hope
12:20 PMCommon Myeloproliferative Neoplasms​ Haris Ali, MD, FACP City of Hope
12:50 PMTreating Myelodysplastic Syndromes in The Community Setting Casey O’Connell, MD, FACP, USC
1:15 PMLunch/Exhibits
1:45 PMNon-CME Presentation
2:30 PMBreak/Exhibits
3:00 PMAML Induction Therapy by Age in 2026 Tamer Othman, MD, City of Hope
3:20 PMWhen to Consider and Refer Patients with MDS/AML for Allogeneic Transplant? Ryotaro Nakamura, MD, City of Hope
3:40 PMPanel Discussion: Myeloid Neoplasms  Lisa Lee, MD, City of Hope; Casey O’Connell, MD, FACP, USC; Haris Ali, MD, FACP, City of Hope; Tamer Othman, MD, City of Hope; Ryotaro Nakamura, MD, City of Hope
4:10 PMSequencing Immunotherapies for Relapsed/Refractory B-cell ALL Ibrahim T. Aldoss, MD, City of Hope
4:35 PMDay One Key Takeaways and Clinical Perspectives  Tanya Siddiqi, MD, City of Hope; Lisa Lee, MD, City of Hope; Ibrahim T. Aldoss, MD, City of Hope
4:50 PMAdjourn

  • Evaluate current and emerging treatment strategies across hematologic malignancies, including myeloid neoplasms, acute leukemias, plasma cell disorders, CLL, and lymphomas.
  • Apply multidisciplinary, evidence-based approaches to therapeutic sequencing, transplant referral, toxicity management, and the integration of novel therapies, including CAR-T cell therapy and bispecific antibodies, into patient care.

Download Here!

Download Here!

How to Get Your Certificate
1. Go to kc.cmecertificateonline.com
2. Click on the 2026 Advancing the Diagnostic-to-Treatment Continuum in Hematologic Malignancies link.
3. Evaluate the meeting.
4. Print, download, or save your certificate for your records.
5. If you lose your certificate, or need help, go to help.cmecertificateonline.com

August 14, 2026
7:45 AMRegistration & Check-in
8:25 AMWelcome and Introductions Tanya Siddiqi, MD, City of Hope; Lisa Lee, MD, City of Hope
8:30 AMUpfront Transplant vs Delayed Transplant in Myeloma: Pros and Cons David R. Oveisi, MD, Cedars-Sinai Medical Center
9:00 AMHow to Incorporate CAR-T/Bispecific Earlier in MM Patients Murali Janakiram, MD, MS, City of Hope
9:30 AMEarly Myeloma Panel Discussion: Sequencing and Toxicity Management Lisa Lee, MD, City of Hope; David R. Oveisi, MD, Cedars-Sinai Medical Center; Murali Janakiram, MD, MS, City of Hope; Ah-Reum (Autumn) Jeong, MD, UC San Diego Health
10:00 AMBreakfast/Exhibits
10:30 AMNon-CME Presentation
10:50 AMExhibits/Break
11: 20 AMMultidisciplinary Approach for the Diagnosis and Treatment of AL Amyloidosis Lisa Lee, MD, City of Hope
11:40 AMKidney Biopsy in Monoclonal Gammopathy of Renal Significance Jonathan E. Zuckerman, MD, PhD, UCLA Health
12:00 PMTherapies on the Horizon for Relapsed/Refractory MM Ah-Reum (Autumn) Jeong, MD, UC San Diego Health
12:20 PMPanel Discussion: Amyloidosis and R/R MM Lisa Lee, MD, City of Hope; Jonathan E. Zuckerman, MD, PhD, UCLA Health; Ah-Reum (Autumn) Jeong, MD, UC San Diego Health
12:40 PMBreak
12:40 PMCurrent Landscape of Relapsed/Refractory Follicular Lymphoma Swetha Kambhampati Thiruvengadam, MD, City of Hope
1:00 PMUpdates in Frontline CLL Combination Therapy Tanya Siddiqi, MD, City of Hope
1:20 PMLunch/Exhibits
1:50 PMNon-CME Presentation
2:35 PMExhibits/Break
3:00 PMManagement of Indolent Lymphomas with Plasmacytic Differentiation – Evolution of BTK Inhibition Benjamin Heyman, MD, City of Hope
3:20 PMCAR-T Cell Therapy vs. Bispecific Antibody Therapy for Second-Line Relapsed DLBCL Geoffrey Shouse, DO, PhD, City of Hope
3:40 PMHodgkin Lymphoma – Current Frontline Management Matthew Genyeh Mei, MD, City of Hope
4:00 PMPanel Discussion: Lymphomas Tanya Siddiqi, MD, City of Hope; Benjamin Heyman, MD, City of Hope; Geoffrey Shouse, DO, PhD, City of Hope; Matthew Genyeh Mei, MD, City of Hope; Swetha Kambhampati Thiruvengadam, MD, City of Hope;
4:30 PMDay Two Key Takeaways and Clinical Perspectives Tanya Siddiqi, MD, City of Hope; Lisa Lee, MD, City of Hope
4:40 PMAdjourn

Speakers

CHAIR

Tanya Siddiqi, MD

Professor, Department of Hematology & Hematopoietic Cell Transplantation
Director, CLL Program
Medical Director, Lymphoma & Immune Effector Cell Therapy (IEC) Programs

CHAIR

Lisa Lee, MD

Associate Clinical Professor
Department of Hematology & Hematopoietic Cell Transplantation
City of Hope Orange County

Ibrahim T. Aldoss, MD

Co-Leader, Leukemia Disease Team
Co-Director, Acute Lymphoblastic Leukemia (ALL) Program
Co-Director, Hematology Tissue Bank
City of Hope

Haris Ali, MD, FACP

Professor
MPN Section Leader, Leukemia Division
Department of Hematology and Hematopoietic Cell Transplantation
Leukemia and Myeloid Malignancies Specialist
City of Hope

Benjamin Heyman, MD

Associate Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation
Lymphoma and CLL Specialist
City of Hope

Murali Janakiram, MD, MS

Hematologist-Oncologist
Associate Professor
Department of Hematology & Hematopoietic Cell Transplantation
City of Hope

Autumn (Ah-Reum) Jeong, MD

Associate Clinical Professor
Division of Hematology and Cellular Therapy
University of California, San Diego

Matthew Genyeh Mei, MD

Professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation
Program Director, Hematology/Oncology Fellowship
City of Hope

Ryotaro Nakamura, MD

Professor, Department of Hematology/Hematopoietic Cell Transplantation
Director, Center for Stem Cell Transplantation, Hematologic Malignancies Research Institute
City of Hope

Casey O’Connell, MD, FACP

Director, Gehr CURES Myeloid Malignancies Program
Jane Anne Nohl Division of Hematology
Keck School of Medicine, USC

Tamer Othman, MD

Hematologist and Medical Oncologist
Department of Hematology & Hematopoietic Cell Transplantation
City of Hope

David R. Oveisi, MD

Assistant Professor, Division of Hematology & Cellular Therapy
Associate Director, Hematology-Oncology Fellowship Program
Cedars-Sinai Medical Center

Geoffrey Shouse, DO, PhD

Assistant Professor, Division of Lymphoma
Department of Hematology & Hematopoietic Cell Transplantation
City of Hope

Swetha Kambhampati Thiruvengadam, MD

Assistant Professor, Lymphoma Division
Department of Hematology & Hematopoietic Cell Transplantation
City of Hope

Jonathan E. Zuckerman, MD, PhD

Associate Professor
Service Chief, Renal Pathology
David Geffen School of Medicine at UCLA

THE LOCATION

Marriott Spectrum Irvine

7905 Irvine Center Drive

Irvine, CA  92618

REGISTRATION OPEN

SPONSOR

Interested in sponsoring the event? Email Gary King by using the link below!

Sponsor